<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-14T03:38:52Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.j00217.00396" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.j00217.00396</identifier>
    <datestamp>2024-11-04T14:21:22Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2024-11-04</dc:date>
  <dc:title>Panax notoginseng saponins ameliorate oral submucous fibrosis by inhibiting ANE-induced oxidative stress in HaCaT cells via activating Nrf2/GCLC signaling pathway</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.j00217.00396</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Objective To investigate the anti-fibrotic effect of Panax notoginseng saponins in arecoline (ANE) -induced oral submucous fibrosis, and to analyze the effect of Panax notoginseng saponins on nuclear factor E2-related factor 2/glutamate-cysteine ligase catalytic subunit (Nrf2/GCLC) signaling pathway.Methods CCK-8 assay was used to evaluate the effects of different concentrations of Panax notoginseng saponins and arecoline on the proliferation of human immortalized keratinocyte cell line (HaCaT). The results of CCK-8 were used to select 75&amp;mu;g/ml arecoline and 25,50,100&amp;mu;g/ml Panax notoginseng saponins as subsequent experimental concentrations. The cells were set as blank control group, model group, and low, medium, and high doses (25, 50, 100 &amp;mu;g/ml) of Panax notoginseng saponins groups. Western blot and RT-qPCR were used to detect the expression of collagen-Ⅰ (COL-1), -smooth muscle actin (&amp;alpha;-SMA), E-cadherin, Nrf2, GCLC protein and mRNA in each group of cells. Immunofluorescence method was used to detect the entry of Nrf2 into the nucleus; biochemical kit was used to detect the content of malondialdehyde (MDA) and superoxide dismutase (SOD) activity in each group of cells; DCFH-DA fluorescent probe was used to detect the content of intracellular reactive oxygen species (ROS).Results Compared with the blank control group, the expression of COL-I protein and mRNA in the model group was up-regulated, and the expression of E-cadherin, Nrf2, GCLC, nuclear Nrf2-related proteins and mRNA were down-regulated. The content of MDA and ROS in the cells increased, and the activity of SOD was significantly reduced;Compared with the model group, the expression of COL-I protein and mRNA was down-regulated, and the expression of E-cadherin, Nrf2, GCLC, nuclear Nrf2-related protein and mRNA were up-regulated in the Panax notoginseng saponins 50 and 100 &amp;mu;g/mL groups. Compared with the model group,the content of MDA and ROS in cells decreased, and the activity of SOD was significantly enhanced (all P &amp;lt; 0.05 or P &amp;lt; 0.01).Conclusion Panax notoginseng saponins have anti-fibrosis effects in HaCaT cells, and their mechanism may be related to the activation of Nrf2/GCLC signaling pathway, thereby resisting oxidative stress and improving oral submucosal fibrosis.</dc:description>
  <dc:subject>oral submucous fibrosis; Nrf2/GCLC signaling pathway; oxidative stress; Panax notoginseng saponins; arecoline</dc:subject>
  <dc:creator>Hong.ZOU</dc:creator>
  <dc:creator>Shuo.QI</dc:creator>
  <dc:creator>Fangping.DENG</dc:creator>
  <dc:creator>Xinyue.ZHANG</dc:creator>
  <dc:creator>Shuxin.FU</dc:creator>
  <dc:creator>Mengqi.GUO</dc:creator>
  <dc:creator>Yufeng.XIAO</dc:creator>
  <dc:creator>Qun.TANG</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>